Form 4: Abbott Laboratories Executive Vice President Reports Stock Disposal
SEC Form 4 Filing
Andrea F. Wainer, Executive Vice President of Abbott Laboratories, reported disposing of 8,339 common shares on February 29, 2024.
Summary
- On February 29, 2024, Andrea F. Wainer, an Executive Vice President at Abbott Laboratories, disposed of 8,339 common shares.
- The transaction was executed at a price of $120.05 per share.
- Following the transaction, Wainer directly owns 70,365 common shares of Abbott Laboratories.
Sentiment
Score: 5
Explanation: The document is a neutral regulatory filing reporting a stock transaction. It doesn't inherently convey positive or negative sentiment.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. The disposal of shares by an executive may be interpreted in various ways by the market, but without additional context, it's difficult to determine the specific reason behind the transaction.
Stakeholder Impact
- The transaction could have a minor impact on shareholders depending on how the market interprets the executive's stock disposal.
Key Dates
| Date | Description |
|---|---|
| 02/29/2024 | Date of transaction: disposal of common shares |
| 03/04/2024 | Date of signature for the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.